Insight

Reza Ghalehtaki: TNT is the new standard of care for LARC

cancernetwork.com

Oct 20, 2024, 12:48

Reza Ghalehtaki: TNT is the new standard of care for LARC

Reza Ghalehtaki, Radiation Oncologist at Cancer Institue of Iran, shared a post on X:

“Hot off the press!!

TNT is the new standard of care for LARC. This review was done to answer some questions regarding the sequence of XRT and chemotherapy in TNT. So happy to have the great Felipe Couñago and Dr. Maria Gambacorta by my side in this paper.

Optimal Sequence for Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: An Evidence-Based Review

Authors: Reza Ghalehtaki, Forouzan Nourbakhsh, Romina Abyaneh, Azadeh Sharifian, Sheyda Pashapour-Khoyi, Mahdi Aghili, Maria Antonietta Gambacorta, Felipe Couñago.“

Azadeh Sharifian cancer chemotherapy Felipe Couñago Forouzan Nourbakhsh LARC Mahdi Aghili Maria Antonietta Gambacorta Maria Gambacorta OncoDaily Oncology Reza Ghalehtaki Romina Abyaneh Sheyda Pashapour-Khoyi TNT XRT

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC